CAD Therapeutics is a biopharmaceutical company developing novel therapeutic candidates targeting post-traumatic stress disorder.
CAD Therapeutics has raised $4.0M in total funding. The most recent round was Series A. The last funding was announced in October 2026.
CAD Therapeutics is headquartered in New York, United States.
CAD Therapeutics is a biopharmaceutical company developing novel therapeutic candidates targeting post-traumatic stress disorder.
CAD Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CAD Therapeutics — Funding & Investors." VCBacked, October 1, 2026, https://www.vcbacked.co/company/cad-therapeutics. Accessed November 5, 2026.
VCBacked. (2026). CAD Therapeutics — Funding & Investors. Retrieved November 5, 2026, from https://www.vcbacked.co/company/cad-therapeutics
{{cite web |title=CAD Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cad-therapeutics |website=VCBacked |access-date=November 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at CAD Therapeutics? Request a listing update